Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
Clinical trial NCT04638491 · COMPLETED
Trial details
- NCT number
- NCT04638491
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2023-11-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.